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Four  new  TPP-based  chromophores  (1-4)  peripherally  functionalized  with  dendrons
containing 2-fluorenyl groups were studied for their potential to serve in photodynamic
therapy. Their linear and nonlinear optical properties were derived. With significant TPA
cross-sections at 790 nm, good singlet oxygen generation capabilities and relatively large
intrinsic  fluorescence,  sensitizers  such  as  1,  might  become  particularly  appealing  for
theranostics.
Due to their large occurrence in nature and biological importance for life, porphyrins have
attracted considerable attention as chromophores for various uses connected with living
organisms. 1 In  particular,  their  capability  to  generate  singlet  oxygen  (1O2)  upon
photoexcitation  has  been  abundantly  studied  for  applications  in  photodynamic  therapy
(PDT),2-4 leading for instance to the clinical  use of selected porphyrin derivatives such as
photofrin® or visudyne®.5, 6 More recently, advances in this field focused in the development
of chromophores possessing larger two-photon absorption (TPA) cross-sections and likely to
be excited with NIR lasers,  thereby allowing for  enhanced penetrability in tissues of  the
exciting beam, better spatial control of the 1O2 generation and overall lower photodamages
to organisms compared to visible excitation.5-9,  # In this connection, porphyrin arrays with
TPA  cross-sections  and  impressive  photosensitizing  activities  have  been  reported.14-17
However, for these compounds the TPA enhancement mostly results from quasi-resonance
of the exciting beam with the one-photon absorbing (OPA) Q state at  low energy.17-19 In
order to obtain photosensitizers without any interfering OPA state,‡ another strategy was
also  explored.  It  consisted  in  functionalizing  the  porphyrin  core  with  good  two-photon
absorbers  at  the  periphery.20 For  such  derivatives,  the  porphyrin-centered  excited  state
active  for  oxygen  photo-sensitizing  can  then  be  populated  by  resonant  energy  transfer
(FRET) following biphotonic excitation of the TPA chromophores. Molecular assemblies with
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dendritic,21-26 dyadic27-29 or even more complex architectures30-33 were successfully tested in
this context.
An even more recent concern in this field is to simultaneously perform imaging and curing
of living tissues in a dual therapic and diagnostic (also called “theranostic”) approach. 20, 34, 35
This  turned  out  to  be  a  quite  challenging  task  to  achieve  with  porphyrin-based
photosensitizers, since the lowest (Q) excited states of porphyrin (which actually sensitizes
oxygen) exhibit often only a modest to negligible fluorescence.36 Apart from few porphyrin
arrays,14 most of the porphyrin-based sensitizers obtained so far are poorer luminophores
than  H2TPP and are therefore only of  modest interest for  imaging purposes.37 Thus,  the
development of analogues of these compounds exhibiting enhanced luminescence remains
an appealing and challenging task.20, 38
Scheme 1. Selected H2TPP-based Photosensitizers.
In  this  respect,  we  wondered  about  the  performances  of  peripherally  functionalized
meso-tetraphenylporphyrins (H2TPP) derivatives such as 1-4. Fluorene is indeed a powerful
fluorophore, 39 giving rise to compounds with fairly high TPA cross-sections, especially when
extended  conjugation  is  present.40 Accordingly,  we  could  previously  show  that  related
dendritic  structures  present  a  significantly  improved  fluorescence  compared  to  that  of
H2TPP, due to an efficient energy transfer taking place from the peripheral fluorene units to
the central TPP core.36,  41,  42 In comparison, preservation of some§ -overlap between the
peripheral fluorenyl units and the central TPP core in 1-4 might even be more beneficial to
both TPA and luminescence.43,  44 Furthermore, given that TPP derivatives are often able to
efficiently  generate  1O2 upon  excitation,  we  also  wondered about  the  potential  of  such
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structures for photodynamic therapy. In line with our expectations, we now show that these
new TPP-based dendritic derivatives constitute quite promising structures for such uses.
The  new  compounds  1-4 were  obtained  in  28-13%  yield  in  one  step  from  the
corresponding functional aldehydes and pyrrole in propionic acid under typical Adler-Longo
conditions.45 The  functional  aldehydes  where  themselves  obtained from the  brominated
aldehydes and aryl the ad hoc arylethynyl precursors following a classic multistep synthetic
approach  based  on  Sonogashira  couplings.  The  resulting  porphyrins  were  completely
characterized by elemental analysis, HRMS, 1H and 13C NMR (see ESI).
Figure 1. Absorption and Normalized Emission Spectra of 1-4 in CH2Cl2.
Their linear optical  properties were subsequently studied.  In line with data previously
gathered on related structures,36, 41, 42 1-4 display the typical features of the porphyrin core
such as an intense Soret band near 426 nm and four weaker Q-bands in the 517-650 nm
range along with a strong structured band near 320 nm corresponding to the fluorene-based
* transition. As expected, the intensity of the latter increases when progressing from 1
to 4 (i.e. with the number of fluorenyl groups in the compound) to eventually become the
most intense UV-vis absorption in  4 (Figure 1). When excited at this particular wavelength
(320 nm), all these molecules fluoresce in the red, corresponding to an emission from the Q-
states which are the lowest singlet excited states, with essentially no fluorescence stemming
from the  fluorenyl-based  * state.  Comparison  between the  absorption  spectra  and
normalized excitation spectra allows pointing out  a  very efficient energy transfer  to the
lowest singlet energy state (above 90 % efficiency) for all compounds. Also, the fluorescence
quantum yields were derived for  1-4 and were shown to be larger or comparable than for
H2TPP (Table 1) or related TPP-based fluorophores.39 In this respect, two fluorenyl units at
the meta-positions appear to be less effective than one fluorene unit in para-position on the
meso phenyl groups of the central TPP core (compare F for 1 and 3). This suggests that 1,4-
conjugation is an important  parameter for  enhancing luminescence.  Otherwise a reverse
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trend than observed between  1 and  3 should have been stated based on the absorption
spectra of these compounds.
TPA cross-sections were then measured for  1-4 by two-photon excitation fluorescence
(TPEF). In line with our expectations, the presence of fluorenyl groups leads to a much larger
effective TPA at 790 nm than for H2TPP. The later shows as strict quadratic dependence on
the power of the incoming laser beam, in line with an instant biphotonic excitation (see ESI),
and opens thereby access to minute spatial control of this phenomenon with  1-4 for any
applied use. Again, comparison between 1 and 3 reveals that  one 2-alkynylfluorenyl group
in para positions to each peripheral meso-phenylene groups of the TPP core is much better
for TPA than two such groups in meta-positions, further outlining the importance of cross-
conjugation  through  the  meso-phenylene  groups.  Albeit  -conjugation  between  the
dendrons and the porphyrin core must be somewhat limited in the most stable (non planar)
conformers,§ this  observation nevertheless  emphasizes  the importance of  that  particular
feature  for  TPA.  Albeit  much lower  than  for  1-4,  the  fluorescence  of  many  commercial
porphyrin-based  photosensitisers  is  often  used  for  one-photon  imaging  during  clinical
trials.37
Table 1. Photophysical data in dichloromethane of selected porphyrin derivatives.a
Cpnd
fluorenes/
porphyrin
absmax
(nm)
UV band
absmax
(nm)
Soret
bsmax
(nm)
Q-bands
em
(nm)
F a  b 1-F- c
2PAmax
(nm)
2max
(GM)d
Enhanc
ement
factor e
H2TPP
0 / 417
514, 549, 590,
647
650, 716 0.11 0.60
0.29
790 12 f 1
1 4 324 427 518, 555, 592,
650
657, 722 0.20 0.70 0.10 790
380 37
2 8 330 425 520, 555, 592,
650
655, 721 0.19 0.65 0.16 790
190 17
3 8 326 427 517, 552, 589,
646
650, 718 0.11 0.59 0.30 790
200 16
4 16 327 426 517, 552, 590,
646
651, 716 0.13 0.56 0.31 790
290 23
a Fluorescence quantum yield determined relative to H2TPP in toluene, upon excitation at the Soret band. b 1O2 formation quantum yield
determined relative to H2TPP in CH2Cl2 (Δ[TPP] = 0.60) upon excitation in the Soret band of the compounds (425 nm). c Upper bound yield
of non radiative decay processes other than intersystem crossing. d Intrinsic TPA cross-sections measured by TPEF in the fs regime; a fully
quadratic  dependence of  the fluorescence intensity  on the excitation power is  observed and TPA responses are fully  non-resonant.  e
2max factor relative to that for H2TPP. f Data from lit.47
While  two-photon  excitation  has  been  demonstrated  for  many  of  them,5,  6 the
corresponding cross-sections compare usually to that of H2TPP (i.e. are typically at least one
order of magnitude below these found for  1-4). In this respect, the presence of large TPA
cross-sections  allied  to  relatively  large  fluorescence  quantum  yields  in  1-4 constitutes
presently a quite appealing property for imaging purposes.
Finally, the quantum yields for singlet oxygen generation were determined for  1-4 (ESI).
Quite interestingly, we found that these are better or compare to that of  H2TPP, revealing
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that  fluorescence is  not  obtained at  the expense of  singlet  oxygen generation for  these
compounds. For  1, this leads to a remarkable 37-fold enhancement of the  2max factor
taken as a figure of merit for two-photon singlet oxygen generation over TPP, while 16- to
23-fold  enhancements  were  obtained  for  2-4 (Table  1),  outlining  the  interest  of  these
compounds  as  biphotonic  sensitizers  for  photodynamic  therapy.  These  enhancements
evidence  the  beneficial  role  of  the  peripheral  fluorene-containing  dendrons  partly  -
conjugated with the central TPP core for biphotonic photosensitization of oxygen. Note that
for 1-4, taking  as a lower bound for the yield of intersystem crossing, the sum F +  is
close to unity. With this kind of structure, this leaves little room for further improvement of
either fluorescence or singlet oxygen generation subsequent to monophotonic excitation.
This  also  means  that  for  these  luminophores,  non  radiative  processes  such  as  internal
conversion contribute less than fluorescence for regenerating the ground state.
In conlusion, we have reported here the photochemical study of four new TPP-
based dendritic  chromophores (1-4)  possessing 4  to 16 ethynylfluorenyl groups at
their periphery. In comparison to  H2TPP, we show that these derivatives possess a
much improved 1O2 generation capability upon biphotonic excitation and also overall
better fluorescence yields. Furthermore, a strict quadratic dependence of the two-
photon excited fluorescence (TPEF) intensity on the fluence of the exciting laser beam
was established in all cases, allowing optimal spatial resolution to be expected from
these chromophores for imaging and therapy. Thus,  1,  2 and  4 present TPA cross-
sections at  790 nm and also a specific red fluorescence which supersede those of
many TPP-based photosensitizers  developed so  far  for  two-photon photodynamic
therapy. These performances can be traced back to their unique structures in which
the peripheral fluorenyl preserve some  -overlap with the central TPP core at the
meso positions, allowing some of them to remain partly conjugated, without strongly
red shifting the lowest porphyrin-based transitions. These peculiar structural features
essentially  preserve  the linear  optic  signature  of  the TPP  core  in  absorption  and
emission and thus afford an optimal transparency window, while inducing an overall
faster  radiative  decay  and  boosting  the  TPA  cross-section  around  800  nm.  In
conclusion,  this  work  emphasizes  the  remarkable  photochemical  properties  of
molecular  assemblies  incorporating  TPP  and  2-fluorenyl  moieties  in  “semi-
disconnected”20 conjugates well known their robustness and photostablity.§§ In regard
to the simplicity and synthetic versatility of their structure, when suitably solubilized
in physiological media by proper functionalization,26 compounds such as 1, likewise to
recently  reported  chlorines,52 might  become  quite  promising  photosensitizers  for
theranostics. Work along these lines and also devoted to study the energy transfer
process in these remarkable compounds is underways.
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Experimental
General procedure for synthesis of 1–4.  A mixture of the corresponding aldehyde
(1.72  mmol)  and  propionic  acid  (6.5  mL)  was  heated  to  120  oC.  After  dropwise
addition of a solution of pyrrole (1 eq) in propionic acid (1.0 mL), the reaction medium
was further kept refluxing for 1.5-5.5 h (see ESI). After cooling at room temperature,
MeOH  was  added  to  the  reaction  mixture  and  the  precipitate  was  filtered.  The
residue  could  be  purified  by  repeated chromatography  on  silica  using  petroleum
ether/CH2Cl2 mixtures as eluant. The title compounds were isolated in 28%-13% yield.
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Notes
# For recent examples of TPA-PDT, see for instance refs 10-13.
‡ The interference between OPA and TPA, can limitate achievement of an optimal 3D-spatial resolution
in some cases. Indeed, it has been shown with some of these compounds that the generation of the
excited state  on the laser  fluence is  not  always strictly  quadratic  at  ambient temperatures in  certain
cases.16, 18
§ In H2TPP, the dihedral angle between the phenyl rings and the macrocycle is not 90° but closer to 60°,
so -conjugation is not fully disrupted. 46
§§ In  this  connection,  they  were  often  used  as  active  molecular  components  for  optical  limitation
puposes.48-51
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